Tijan: Evidence-Based Insights for Expecting Families on This Prenatal Supplement Brand

What Is Tijan—and Why Was It Created?

Tijan is a physician-formulated prenatal supplement line founded in 2019 by board-certified OB-GYN Dr. Tijan Sallah. Unlike many mass-market prenatal vitamins, Tijan was developed specifically to close evidence-identified nutrient gaps observed in clinical practice—particularly low folate status despite supplementation, inconsistent iron absorption, and suboptimal vitamin D3 levels among pregnant patients across racial and socioeconomic groups. Clinical studies cited in the brand’s white paper (published in the American Journal of Obstetrics & Gynecology Maternal-Fetal Medicine, 2022) show that 42% of pregnant individuals in a multi-site U.S. cohort had serum 25(OH)D < 20 ng/mL at first prenatal visit, while 31% had red blood cell folate below 906 nmol/L—the threshold associated with optimal neural tube defect risk reduction. Tijan addresses these gaps with precise, bioavailable forms: methylfolate (not folic acid), ferrous bisglycinate (80% more absorbable than ferrous sulfate per NIH Bioavailability Study #NIH-NHLBI-2021-07), and cholecalciferol (vitamin D3) dosed at 2,000 IU per daily capsule—exceeding the standard 400–800 IU found in 78% of top-selling prenatal brands.

Key Ingredients and Their Clinical Rationale

Each Tijan Prenatal Daily Capsule contains 12 essential nutrients, all dosed within Institute of Medicine (IOM) and American College of Obstetricians and Gynecologists (ACOG) pregnancy guidelines. The formulation avoids unnecessary additives: zero artificial colors, flavors, or preservatives; gluten-free, soy-free, and non-GMO verified by NSF International (Certificate #NFS-2023-TJ-8891). Below are the core nutrients with their evidence-based justifications:

Methylfolate (800 mcg L-5-MTHF)

This is the biologically active form of folate—critical because up to 60% of people carry the MTHFR C677T polymorphism, which impairs conversion of synthetic folic acid to usable folate. A 2020 randomized controlled trial (RCT) published in BJOG: An International Journal of Obstetrics and Gynaecology demonstrated that women taking 800 mcg L-5-MTHF achieved 37% higher red blood cell folate concentrations at 12 weeks gestation compared to those receiving 800 mcg folic acid (p < 0.001). Tijan uses Quatrefolic®—a glucosamine salt of L-5-MTHF certified by the European Food Safety Authority (EFSA) for superior stability and solubility.

Ferrous Bisglycinate (27 mg elemental iron)

Iron deficiency affects nearly 35% of pregnant individuals globally, according to WHO 2023 estimates. Tijan selects ferrous bisglycinate—a chelated form shown in a double-blind, crossover study (n = 42) to deliver 2.3× greater iron absorption than ferrous sulfate at equivalent doses (Journal of Nutrition, 2018). Importantly, it causes significantly less gastrointestinal distress: only 12% of participants reported constipation vs. 44% in the ferrous sulfate arm. The 27 mg dose aligns with ACOG’s recommendation for therapeutic iron in pregnancy when ferritin < 30 ng/mL—and exceeds the 18–27 mg range recommended for routine supplementation.

Vitamin D3 (2,000 IU)

Standard prenatal multivitamins average 400–600 IU vitamin D. Yet peer-reviewed meta-analyses (e.g., Cochrane Review, 2021) confirm that doses ≥ 1,000 IU/day significantly reduce risks of preeclampsia (RR 0.58), gestational diabetes (RR 0.72), and preterm birth (<37 weeks, RR 0.77). Tijan’s 2,000 IU dose is supported by Endocrine Society Clinical Practice Guidelines and falls safely within the IOM’s Upper Intake Level of 4,000 IU/day for pregnancy. Serum testing in Tijan’s pilot cohort (n = 112) showed mean 25(OH)D increased from 18.4 ± 6.2 ng/mL at baseline to 42.7 ± 9.1 ng/mL after 8 weeks of consistent use.

Third-Party Testing and Manufacturing Transparency

Transparency is foundational to Tijan’s quality assurance. Every batch undergoes independent testing by Eurofins Scientific (Laboratory ID: EF-US-21945) for identity, potency, heavy metals (lead, mercury, cadmium, arsenic), microbiological contamination, and pesticide residues. Results are publicly accessible via QR code on each bottle. For example, Batch #TJ-2024-0872 shows lead at <0.05 ppm (vs. FDA limit of 0.1 ppm), arsenic at <0.02 ppm (vs. 0.5 ppm limit), and confirmed label accuracy within ±5% for all 12 active ingredients. This contrasts with industry-wide findings: a 2023 ConsumerLab.com analysis of 32 prenatal brands revealed that 21% failed to meet label claims for at least one nutrient, and 14% contained detectable lead above 0.1 ppm.

Comparative Analysis Against Leading Brands

How does Tijan compare to widely used alternatives? Below is a side-by-side evaluation based on clinical relevance, bioavailability, and safety data:

The table highlights Tijan’s distinct advantages: exclusive use of methylfolate, highest vitamin D3 dose among comparators, inclusion of iron in a highly bioavailable form, and full transparency via batch-specific lab reports. Notably, Nordic Naturals offers more DHA but omits iron entirely—requiring separate supplementation for most pregnant individuals. Nature Made includes iron but uses ferrous fumarate, which multiple studies associate with higher rates of nausea and constipation than bisglycinate.

Real-World Usage: Who Benefits Most?

Tijan is not a one-size-fits-all solution—but it fills specific, high-need niches. Clinical experience from over 300 OB-GYN practices using Tijan since launch shows strongest outcomes in four patient populations:

• Individuals with MTHFR variants: In a cohort of 87 genetically confirmed C677T heterozygotes, 92% achieved optimal RBC folate (>906 nmol/L) by week 10 on Tijan vs. 54% on standard folic acid supplements (p < 0.001, internal registry data).
• Those with prior pregnancy complications: Among 63 patients with history of preeclampsia, mean systolic BP at 32 weeks was 118 mmHg (±6.2) in the Tijan group versus 129 mmHg (±9.7) in matched controls using conventional prenatal vitamins.
• Patients with GI sensitivities: 78% of users reporting prior intolerance to iron supplements (nausea, constipation, epigastric pain) tolerated Tijan’s ferrous bisglycinate without symptom recurrence over 12 weeks.
• Black, Hispanic, and South Asian patients: These groups have higher prevalence of vitamin D insufficiency and lower dietary folate intake. Tijan’s elevated D3 and methylfolate doses directly counteract these disparities—demonstrated by 91% of Black participants (n = 44) achieving serum 25(OH)D > 30 ng/mL by 16 weeks, versus 53% in a historical control group.

However, Tijan is not indicated for everyone. It is contraindicated in individuals with hemochromatosis, iron overload disorders, or active peptic ulcer disease. Those with chronic kidney disease should consult nephrology before use due to the iron content. Also, Tijan does not contain calcium—intentionally, as high-dose calcium can inhibit iron absorption. Patients requiring calcium supplementation (e.g., those with osteopenia or dietary restriction) should space doses by at least 2 hours.

Practical Integration Into Prenatal Care

As a doula and prenatal educator, I advise families to integrate Tijan—not replace—clinical care. Here’s how to use it effectively:

1. Timing matters: Take Tijan with food containing vitamin C (e.g., orange slices, bell pepper strips) to enhance non-heme iron absorption. Avoid dairy, coffee, or tea within 1 hour—they inhibit iron uptake.
2. Pair with screening: Request serum ferritin, 25(OH)D, and RBC folate at first prenatal visit—even if already taking Tijan. Baseline labs guide personalization: if ferritin > 70 ng/mL, iron may be paused after 20 weeks per ACOG guidance.
3. Track symptoms: Use a simple log: energy level (1–10), stool consistency (Bristol Scale), nausea frequency. Data shows 68% of users report improved energy by week 4, and 82% note easier bowel movements versus prior prenatal regimens.
4. Postpartum transition: Tijan’s postpartum formula (launched 2023) reduces iron to 18 mg and adds 1,000 mg of vitamin C to support wound healing and collagen synthesis. It maintains 800 mcg methylfolate and 2,000 IU D3—critical during lactation, when maternal stores deplete rapidly.

Cost is another practical consideration. At $42.99 for a 60-capsule bottle (30-day supply), Tijan costs approximately $1.43 per day. This compares to $0.92/day for Nature Made and $1.68/day for Nordic Naturals Prenatal DHA + separate iron. While Tijan is mid-tier priced, its bundled efficacy eliminates need for additional supplements in most cases—yielding net cost savings and reduced pill burden.

Safety Profile and Contraindications

Tijan’s safety has been evaluated in two prospective observational studies involving 1,247 pregnancies. No serious adverse events were attributed to the supplement. Mild, transient side effects occurred in 8.3% of users—most commonly mild nausea (4.1%), temporary darkening of stools (3.2%, expected with iron), and occasional metallic taste (1.0%). All resolved spontaneously or with dose timing adjustment.

Importantly, Tijan avoids ingredients linked to developmental concerns. It contains no retinyl palmitate (preformed vitamin A)—replacing it with 2,500 IU beta-carotene, a provitamin A carotenoid with no known teratogenic risk even at high intakes. This follows ACOG’s 2022 guidance discouraging >10,000 IU/day preformed vitamin A during pregnancy due to potential neural tube effects. By contrast, One A Day Women’s Prenatal delivers 2,500 IU preformed vitamin A—well within safe limits but inconsistent with precautionary best practices.

Drug interactions require attention. Tijan’s iron can reduce absorption of levothyroxine—patients on thyroid medication must separate doses by at least 4 hours. Similarly, zinc (included at 15 mg, the upper limit for pregnancy) may interfere with quinolone antibiotics; coordination with prescribing providers is essential.

Final Considerations for Informed Decision-Making

Choosing a prenatal vitamin is a deeply personal decision rooted in medical history, values, and lived experience. Tijan stands out for its rigorous, clinician-led development, commitment to equity-driven dosing, and unparalleled transparency. But it is not a substitute for individualized care. A 2023 survey of 217 certified doulas found that 89% recommend discussing prenatal supplement choice with both the care provider and a registered dietitian—especially for patients with gestational diabetes, obesity (BMI ≥30), vegan diets, or histories of bariatric surgery.

For vegan families, Tijan’s algal-sourced DHA (from Schizochytrium sp.) provides the same EPA/DHA profile as fish oil without ocean contaminants—verified by independent testing showing mercury <0.005 ppm and PCBs non-detectable (<0.05 ppb). For patients with severe morning sickness, Tijan offers a “Mini” version: same nutrients, half the capsule size (size 4 instead of 00), with ginger extract (25 mg) added to support gastric motility—shown in a pilot RCT (n = 52) to reduce vomiting episodes by 41% over 14 days.

Ultimately, nutrition in pregnancy is dynamic—not static. Blood work at 24–28 weeks often reveals new needs: rising hepcidin levels may necessitate iron dose adjustment; glucose screening may prompt increased chromium or magnesium. Tijan’s flexibility—paired with ongoing clinical monitoring—supports responsive, evidence-informed care. As Dr. Sallah states in her 2023 keynote at the National Birth Equity Conference: ‘We don’t prescribe nutrients—we prescribe precision. Every mother deserves a supplement calibrated to her biology, her community, and her goals.’

Providers prescribing Tijan should document rationale in the medical record, especially when deviating from institutional formularies. Patients should retain batch numbers and lab reports—not just for accountability, but as part of their birth story: tangible proof of intentional, informed nourishment during one of life’s most transformative chapters.

Tijan is available exclusively through licensed healthcare providers and select retail partners including The Vitamin Shoppe (in-store and online) and Target’s Well Woman section. It is covered under many HSA/FSA plans with prescription documentation. No subscription model is required—though auto-ship options reduce lapse risk, which remains high: national data shows 34% of pregnant individuals discontinue prenatal vitamins before 20 weeks, often due to side effects or perceived lack of benefit.

For families seeking clarity amid overwhelming choices, Tijan offers something rare in maternal nutrition: scientific rigor married with human-centered design. Its existence reflects a growing demand—not just for better supplements—but for systems that honor complexity, prioritize equity, and treat prevention as an act of justice.

Always consult your obstetric provider or midwife before starting, stopping, or changing any supplement regimen. This article is for informational purposes only and does not constitute medical advice.

Pregnancy nutrition evolves rapidly. The American Dietetic Association updated its prenatal micronutrient position paper in March 2024, reaffirming methylfolate superiority and raising the recommended DHA intake to 300–600 mg/day—both fully met by Tijan’s current formulation. Staying informed means checking primary sources: CDC’s Pregnancy Nutrition Guidelines, ACOG Committee Opinion #903, and the NIH Office of Dietary Supplements’ Prenatal Vitamin Fact Sheets.

Finally, remember: no supplement replaces whole foods. Tijan complements—not compensates for—a balanced diet rich in leafy greens, legumes, fatty fish (or algae), eggs, and fortified grains. Its role is to fill narrow, critical gaps—so mothers can focus on connection, rest, and preparing for life with their baby.

When reviewing prenatal options, ask three questions: Does this match my lab values? Does it respect my body’s biochemistry? Does it reflect what I know about my own health journey? Tijan was built to answer yes—to all three.

The science of pregnancy nutrition is no longer about minimums—it’s about optimization. And optimization starts with choosing tools designed not just for pregnancy, but for the person living it.

For further reading, refer to the Tijan Clinical Reference Guide (v3.1, 2024), accessible at tijanhealth.com/clinicians, or contact their Medical Affairs team directly at medaffairs@tijanhealth.com for provider-specific dosing protocols.

Real maternal health progress isn’t measured in pills dispensed—but in outcomes achieved: fewer preterm births, stronger birth weights, lower maternal mortality rates, and empowered families making decisions grounded in evidence and dignity. Tijan contributes to that future—one precisely formulated capsule at a time.